AI devices with FDA product code OIW — Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types
Product code OIW (“Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types” in openFDA) covers 4 devices on the FDA AI-enabled list, from 3 companies. Most are reviewed by the Clinical Toxcicology panel (4). The most recent decision was Tissue of Origin Test Kit-FFPE on March 15, 2018.
4AI devices
3Companies
2008First decision
2018-03-15Latest decision
Trend: devices per year
2008201020122018
Top companies
All 4 devices, newest first
- Tissue of Origin Test Kit-FFPECancer Genetics, Inc. · Clinical Toxcicology
- TISSUE OF ORIGIN TEST KIT FFPEPATHWORK DIAGNOSTICS, INC. · Clinical Toxcicology
- PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPEPATHWORK DIAGNOSTICS · Clinical Toxcicology
- PATHWORK DIAGNOSTICS TISSUE OF ORIGIN TESTPATHWORK DIAGNOSTICS, INC. · Clinical Toxcicology